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Introduction
■ Cancer is a group of diseases that is characterized by 
uncontrollable cell growth. 
■ Cancer accounts for 1 in every 4 deaths in the United States 
■ Therefore, it is crucial to discover novel anticancer compounds 
to both prevent and treat cancer. 
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Introduction
■ Previous generations of drugs for cancer treatment were discovered 
largely from a limited number of chemical entities and these drugs 
usually target the general cellular machinery related to cell proliferation.
■ Such therapies are toxic to not only cancer cells but also normal fast-
growing cells. 
■ The new drug targets may be specifically altered only in cancer cells, 
allowing development of drugs specially targeted towards cancer cells. 
■ The overall objective of this study was to identify small molecule 
compounds synthesized through combinatorial chemistry as candidates 
for anti-cancer drug development.
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Materials and methods
cell culture:
■ Cancer cell lines:
– K562 (human chronic myelogenous leukemia (CML) 
cells),
– HeLa (cervical cancer cells),
– AGS (gastric adenocarcinoma cells) were obtained from 
the American Type Culture Collection (ATCC). 
■ K562, HeLa, and AGS cells were cultured in RPMI 1640 
medium with 10% Fetal Bovine Serum and 1% antibiotics 
(PSA). 
■ Cells were incubated in 5% CO2 at 37°C and were given 
medium and plate changes as needed. 5
Materials and methods
Drug library and screening:
■ A library of 2,560 small compounds was purchased.
– One-hundred nanoliters of drug was transferred into 100 μl of culture medium in 96-
well plates and the final concentration was approximately 10 μM for each drug.
– K562 cells were then added into the wells at a density of 3,000 cells/well. 
– Plates were incubated for three days at 37°C and 5% CO2.
– Viable cell number was assessed.
– and the optical density (OD) values were recorded. 
■ OD value for each experimental well was converted to cell number based on the standard 
curve
■ Growth inhibition was calculated by first subtracting the original number of cells seeded 
(3,000), and then using the following formula:
GI = (control cell number – experimental cell number)/control cell number 
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Materials and methods
Evaluation of 50% growth inhibition (GI50) by 
proliferation assay:
■ Cancer cells (K562, HeLa, and AGS) were prepared and diluted to a concentration of 
3.5 x 104cells/mL.
■ The center 6 x 10 wells of the 96-well plates were seeded with the cell suspension, 
totaling 3.5 x 103cells/well.
■ The border wells of the 96-well plates were seeded with autoclaved water to minimize 
evaporation of the center wells. 
■ The plates were incubated in 5% CO2 at 37°C overnight, giving ample time for 
adherent cell lines to attach to the plates. 
■ Plates were then incubated for another three days.
■ estimated the number of viable cells in each well 
■ The data was then analyzed to construct a GI50 curve and calculate the GI50 value 
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Materials and methods
Analysis of apoptosis and DNA contents:
■ Annexin V is a 35-36 kDa Ca2+ dependent phospholipid-binding protein that has 
a high affinity for the plasma membrane phospholipid phosphatidylserine (PS),
and binds to cells with exposed PS, one of the earliest features of apoptosis.
■ Annexin V staining precedes the loss of membrane integrity which accompanies 
the latest stages of cell death resulting from either apoptotic or necrotic processes
■ Therefore, staining with Annexin V is typically used in conjunction with a DNA-
binding dye such as 7-amino-actinomycin (7-AAD) which is excluded by viable 
cells with intact membranes, while the membranes of dead or damaged cells are 
permeable to 7-AAD. 
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Materials and methods
Analysis of apoptosis and DNA contents:
Analysis of apoptosis :
– K562 cells were prepared and seeded in 24-well at a concentration of 
5 x 104 cells/well in 2 mL RPMI medium 
– Compounds were prepared and added to the wells at a concentration 
of 5 μM. 
– Cells were incubated in 5% CO2 at 37°C for 24 hours.
– Then, cells were collected and washed twice with PBS, centrifuged, 
and the supernatant was removed. 
– Cells were resuspended in 1x Annexin V Binding Buffer 
– PE Annexin V and 7-AAD was added to the suspension. 
– The suspension was gently mixed and incubated for 15 minutes in the 
dark at room temperature.
– Samples were analyzed by flow cytometry
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Materials and methods
Analysis of apoptosis and DNA contents:
■ Propidium iodide (PI) is an intercalating agent and a fluorescent molecule that can be used to stain 
cells.
■ PI can be used as a DNA stain for both flow cytometry, to evaluate DNA content in cell cycle analysis 
and cell viability, and microscopy to visualize DNA containing organelles such as the nucleus. 
DNA contents analysis:
– K562 cells were also analyzed for DNA contents by propidium iodide (PI) staining. 
– Briefly, cells were seeded in 6-well multidishes at a concentration of 1 x 106 cells/well in 3 mL 
of RPMI medium. 
– Cells were incubated in 5% CO2 at 37°C. Samples were collected at 24 hour time intervals for 3 
days. 
– Cell suspensions were transferred to a 5 mL polystyrene tube , centrifuged, and had the 
supernatant removed and cells were treated with a PI/RNase Staining Buffer and incubated for 
15 minutes at room temperature in darkness. 
– Cells were analyzed for DNA contents using flow cytometry
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Materials and methods
Western blotting:
■ Cells were harvested and washed, and lysed in M-PER Mammalian 
Protein Extraction Reagent supplemented with 1% Halt Protease and 
Phosphatase Inhibitor Cocktail for 15 minutes.
■ Samples were then centrifuged at 13,000 rpm for 10 minutes at 4°C and 
the supernatant was collected.
■ Protein concentration was measured using a Nanodrop 1000 
Spectrophotometer 
■ proteins were separated by SDS-PAGE and transferred to PVDF 
membranes 
■ Immuno-positive bands were photographed on X-ray films 
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Results
High throughput screening of compound library:
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Results
Secondary evaluation of nine selected compounds using 3 cancer 
cell lines:
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Results
Determination of GI50 for compound C505:
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Results
C505 kills cancer cells via induction of 
apoptosis :
 viable cells are :
 7-AAD and Annexin V negative;
■ early apoptotic cells are:
 Annexin V positive and 7-AAD negative,
 while cells in late apoptosis and dead cells are:
 both Annexin V and 7-AAD positive. 
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Results
Propidum iodide (PI) staining for apoptosis and cell cycle 
analysis:
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Results
C505 induces caspase-dependent apoptosis:
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Discussion
■ In this study, we identified one compound with potent anti-cancer activity from a library 
of 2,560 potential drug compounds. 
■ The selected compound C505 exhibited toxicity at very low concentrations(GI50 < 0.16 
μM) against all three cancer cell lines (K562, HeLa, and AGS) tested.
■ C505 is a piperazine-containing compound that was shown in this study for the first time 
to possess potent anticancer activity.
■ The piperazines are a large class of chemical compounds, many of which have important 
pharmacological properties.
■ Many currently notable drugs contain a piperazine ring as part of their molecular 
structure. Examples include antianginals, antidepressants, antihistamines, antipsychotics, 
urologicals, and recreational drugs. Indeed, imatinib, which has potent anti-leukemia 
activity and is used as a positive control drug in this study, is a piperazine derivative 
■ Given the high potency of C505 and the potentially excellent pharmacological 
properties, C505 is an excellent candidate that may be further developed into an 
anticancer drug.
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Discussion
■ series of experiments was also conducted to determine the cellular and 
molecular mechanism underlying the killing activity of C505. 
■ Annexin V/7-AAD staining as well as PI staining indicates that C505 can 
kill cancer cells via the induction of cell cycle arrest and apoptosis.
■ Western blotting analyses suggest that C505-induced apoptosis is 
caspase-dependent as several caspases including caspase-8 and caspase-3 
are activated by C505 treatment 
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conclusion
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In conclusion, we discovered a novel piperazine
compound with potent anticancer activity through high 
throughput screening of a drug-like compound library. 
This compound effectively inhibits cancer cell 
proliferation and induces caspase-dependent apoptosis 
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